Prevention of sudden cardiac death

Clinical Cardiology

Volumn 28, Issue SUPPL., 2005, Pages 12-18

  Prystowsky, Eric N ^a  

^a Care Group   (United States)

Author keywords

Antiarrhythmic drugs; ICD; Implantable cardioverter defibrillator; SCD; Sudden cardiac death; Ventricular arrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ATAXIA; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; DEFIBRILLATOR; DISEASE ASSOCIATION; DRUG EFFICACY; FATALITY; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; INSOMNIA; MORTALITY; OUTCOMES RESEARCH; PHOTOSENSITIVITY DISORDER; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SUDDEN DEATH; TREMOR; VISUAL DISORDER;

EID: 27744457677     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960281304     Document Type: Review

References (32)

1. State-specific mortality from sudden cardiac death-United States, 1999. MMWR 2002;51:123-126
2. Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ: Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985;312:193-197
3. Cannom DS, Prystowsky EN: Evolution of the implantable cardioverter defibrillator. J Cardiovasc Electmphysiol 2004;15:375-385
4. Buxton AE: Identifying the high risk patient with coronary artery disease-is ejection fraction all you need? J Cardiovasc Electrophysiol 2005;16(suppl 1):S25-S27
5. Klein GJ, Krahn AD, Skanes AC, Yee R, Gula LJ: Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy. J Cardiovasc Electmphysiol 2005;16(suppl 1):S28-S34
6. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK: Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000.J Am Med Assoc 2002;288:3008-3013
7. Chadda K, Goldstein S, Byington R, Curb JD: Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503-510
8. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-1890
9. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-1940
10. AVID Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-1583
11. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781-788
12. Cairns JA, Connolly SJ, Roberts R, Gent M: Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675-682
13. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P: Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667-674
14. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82
15. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R: Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344:493-498
16. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237
17. Wyse DG, Talajic M, Hafley GE, Buxton AE, Mitchell LB, Kus TK, Packer DL, Kou WH, Lemery R, Santucci P, Grimes D, Hickey K, Stevens C, Singh SN: Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): Drug testing and as-treated analysis. J Am Coll Cardiol 2001;38 344-351
18. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
19. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ: Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488
20. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp PJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J: Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853
21. Kass DA: Cardiac resynchronization therapy. J Cardiovasc Electrophsysiol 2005;16(suppl 1):S35-S41
22. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM: Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004:350:2140-2150
23. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B: Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302
24. Kuck KH, Cappato R, Siebels J, Ruppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-754
25. Domanski MJ, Sakseena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 1999;34:1090-1095
26. Hallstrom AP, McAnulty JH, WilkoffBL, Follmann D, Raitt MH, Carlson MD, Gillis AM, Shih HT, Powell JL, Duff H, Halperin BD: Patients at lower risk of arrhythmia recurrence: A subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. J Am Coll Cardiol 2001;37:1093-1099
27. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M: Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian Implantable Defibrillator Study. Circulation 2000;101:1660-1664
28. Exner DV, Sheldon RS, Pinski SL, Kron J, Hallstrom A: Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from Implantable Defibrillator Therapy? Evaluation of the Canadian Implantable Defibrillator Study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable defibrillators trial. Am Heart J 2001;141:99-104
29. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P: Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: Eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation 2004;10:112-116
30. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM: Atrial fibrillation in the sitting of acute myocardial infarction: The GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronaiy Arteries. J Am Coll Cardiol 1997;30:406-413
31. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie JL, Scavee C, Bordachar P, Clementy J, Haissaguerre M: Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004;351:2373-2383
32. Prystowsky EN, Nisam S: Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial. Am J Cardiol 2000;86:1214-5, A5